Tag Archives: biomarkers
A study based on blood samples from more than 100 ovarian cancer patients and 700 women without ovarian cancer suggested that the HE4 might be useful to use for women … Continue reading
The Society of Gynecologic Oncologists (SGO) has issued a comprehensive white paper — as part the organization’s professional Gynecologic Cancer Collaborative education program — that provides an overview of and … Continue reading
The Path to Personalized Medicine Margaret A. Hamburg, M.D., and Francis S. Collins, M.D., Ph.D. Major investments in basic science have created an opportunity for significant progress in clinical medicine. … Continue reading
Almost three quarters of ovarian cancer cases are diagnosed at advanced stages, making this disease the most lethal gynecologic malignancy in U.S. women. Using sera from a total of 1400 … Continue reading
Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.
Detection of autoantibodies against tumor-associated antigens (TAA) has recently been shown to be a powerful tool for early detection of various cancers. The aim of this study was to investigate … Continue reading
Scientists have established the presence of certain proteins in ovarian cancer tissues and have linked these proteins to poor survival rates in women with advanced stages of the disease. The … Continue reading